Videos

During this epidemic of burnout, we have to remember to love and take care of ourselves.

"Too often summer days appear, Emblems of perfect happiness, I can't confront..."

What risks are around us now?

You've heard about winter seasonal affective disorder, but what about summer?

"By the first of August, the invisible beetles began to snore and the grass was as tough as hemp and was no color..."

Today is the somber anniversary of the Nagasaki bombing.

"...everything known and unknown for longer than I have searched or breathed, the infinity of my ignorance."

Have you seen "Oppenheimer"? This movie has H. Steven Moffic, MD, contemplating the long-lasting fallout...

"The dark pours down, sticky as Coke, but the light from the kitchen gleams like a beacon."

Things learned in retirement...

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, provide their practice pearls for community psychiatrists and psychiatric nurse practitioners who care for patients with major depressive disorder (MDD) to optimize their treatment and management.

Experts provide an overview of novel treatments, including glutamatergic, GABAergic, and psychedelic drugs, that are either approved or currently being evaluated in clinical studies for MDD (major depressive disorders).

You matter, but what does mattering really mean?

"So many things look absurd from a distance that people still take seriously..."

What future awaits our grandchildren?

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, discuss the typical strategies for switching therapies for major depressive disorder (MDD).

Practitioners discuss the need to treat patients with major depressive disorder (MDD) to a complete remission vs a decline in symptomology.

"At O'Hare, at Atlanta, at Dallas/Fort Worth, it happens every trip, at LaGuardia, Logan, and Washington Dulles, the customary strip..."

The CEO of the AFSP discusses the big 1-year anniversary of the National Suicide Prevention Lifeline switch to 988.

Need some summer reading recommendations?

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, discuss best practices for monitoring and follow-up with patients with major depressive disorder (MDD) to ensure treatment efficacy and safety.

Practitioners discuss their approach to treatment with their patients with major depressive disorder (MDD).

"She was clear-eyed and dying when I knew her, soft breaths feathering from her chest like distant smoke..."

Experts discuss how practitioners are viewing major depressive disorder (MDD) as a chronic condition vs an episodic condition.

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, discuss navigating the challenge of a “one size fits all approach” when treating and identifying the specific needs of patients with major depressive disorder (MDD).

What can we do on a national level to improve mental health?

"The Child is father of the Man..."

Are you going on vacation this year?

Practitioners discuss the rates of undertreatment in patients suffering from major depressive disorder (MDD).

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, comment on the perception of major depressive disorder (MDD) within the healthcare community and the clinical and practical implications of is this condition.